Article
Platelet-rich plasma induces mixed osteogenic/osteoclastogenic phenotype in osteosarcoma SaOS-2 cells: role of TGF-beta.
Current pharmaceutical biotechnology - 1 Jan 2014
Martinotti Simona, Mazzucco Laura, Balbo Valeria, Patrone Mauro, Mozzati Marco, Ranzato Elia, Burlando Bruno
Abstract excerpt
Platelet-rich plasma (PRP) is widely used to promote tissue repair and accelerate osteogenesis, but there is no agreement about its mechanism of action. We characterized the modulatory effect of PRP on the in vitro osteoblast model SaOS-2, by using cell motility/chemoattraction and osteogenesis/mineralization assays, and a series of osteogenic/ osteoclastogenic genomic markers. Scratch wound assay showed that PRP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
